|
Title: A male patient is receiving rituximab therapy for non-Hodgkin's lymphoma. Which of the following ... Post by: JUJU1791 on Jan 25, 2018 A male patient is receiving rituximab therapy for non-Hodgkin's lymphoma. Which of the following would be a priority nursing intervention to reduce the risk for cytotoxicity and tumor lysis syndrome?
A) Ensure that the patient maintains a normal breathing pattern. B) Ensure that the patient maintains a normal fluid and electrolyte balance. C) Protect the patient from exposure to infections. D) Monitor the patient for deterioration in renal function. Title: A male patient is receiving rituximab therapy for non-Hodgkin's lymphoma. Which of the following ... Post by: GaryManini on Jan 25, 2018 Content hidden
|